Next Vial logo

Next Vial Review

7.1
★★★★☆3.6/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10

Best for: compounded GLP-1, LegitScript-certified, with a named pharmacy partner

Next Vial scores highest on state availability and ease of access.

Offer61%Off

Next Vial discount & current deal

Semaglutide$78/mo was$199

Discounted price; confirm terms at checkout

Semaglutide

$78/mo intro price

then $199/mo ongoing

Tirzepatide

$127/mo intro price

then $249/mo ongoing

Price checked on Next Vial’s site,

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not stated

Coaching

Not stated

Get the $78/mo deal →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options. LegitScript certified with medication dispensed through Manifest Pharmacy (Greer, SC). No membership required: one transparent price covers consultation, medication, and free shipping. Serves 49 states.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideMicrodoseLegitScript certifiedFree shippingNo membership

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to Next Vial

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Next Vial logo
3.6 / 5
Our editorial rating
Visit Next Vial →

from $199/mo (after intro offer) · no insurance needed

Next Vial at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$199/mo (after intro offer) ($78 intro price)
What's included
Medication · Consult · Shipping
Availability
49 states
FDA status
No FDA warning letter on record

How we scored Next Vial

Each dimension is scored algorithmically from Next Vial’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.5/10

At $199/mo (after intro offer), Next Vial runs about 11% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $78.

Effectiveness25%

7.9/10

Next Vial offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

7.1/10

Online intake and platform experience (consult included in the price); 7 platform features disclosed.

Trust & Safety15%

7.0/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

8.0/10

Next Vial is available in 49 states: all but Alaska.

Support10%

5.6/10

Next Vial provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Next Vial review

Last checked November 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed availability in 49 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$199–$249/mo across 2 dose/plan tiers (checked November 2026)
State pharmacy licensing & LegitScript status
LegitScript certified
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Next Vial

We walked Next Vial’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Take a 100% online health questionnaire / intake form.
  2. 2A U.S. board-certified physician reviews records and prescriptions.
  3. 3Medications are delivered free from accredited pharmacies.
Price shown only after intake
  • No price is shown before or after the questionnaire on the pages reviewed, despite an 'upfront pricing' claim.
  • States 'no insurance, no waitlist, free delivery' and 'no membership required.'
  • Offers compounded and microdose semaglutide and tirzepatide.

GLP-1 medications Next Vial offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

StandardCompounded
$199$78/mo
Save 61% right now
semaglutide
StandardCompounded
$249$127/mo
Save 49% right now
tirzepatide

Ready to get started?

Plans and promotions change often, so check Next Vial's current pricing and active discounts before you decide.

See Next Vial pricing →

What we like

  • LegitScript certified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
  • No membership fees: one all-in price covering consultation, medication, and shipping
  • Compounded semaglutide, tirzepatide, and microdose options available
  • Free rushed shipping; serves 49 states nationwide
  • Board-certified physician oversight with ongoing provider support

Watch-outs

  • Lowest monthly rates require prepaying 6 or 12 months up front
  • Compounded medications are not FDA-approved
  • Labs and nutritional coaching not disclosed
  • Microdose pricing not published on product page
  • Alaska not listed among served states

Is Next Vial worth it?

The short version of what Next Vial offers is compounded GLP-1, LegitScript-certified, with a named pharmacy partner. New patients start at $78/month as an intro price, but the price steps up to $199/month after the intro period, so treat the headline number as an intro offer, not the standing rate. No single feature of its GLP-1 program sets it apart from the category on its own, so the price and terms below are the things to compare.

Worth knowing before you sign up: Next Vial offers a microdosing option and is LegitScript-certified.

How much Next Vial costs

  • Compounded semaglutide is currently $78/month on an intro offer, regularly $199/month, at that tier.
  • Compounded tirzepatide is currently $127/month on an intro offer, regularly $249/month, for that option.

Because Next Vial's headline figure is listed as “after intro offer”, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Next Vial with the month-to-month prices of the alternatives below instead.

Belle Health (about $199/month) is one of the closest alternatives to weigh Next Vial against.

Medications: what Next Vial prescribes

Next Vial prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy, which is why the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.

Who Next Vial is best for, and who should skip it

A good fit if you…

  • want a straightforward telehealth GLP-1 program and are comfortable comparing it against the alternatives below.

Look elsewhere if you…

  • specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
  • need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

Next Vial is available in 49 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.

Bottom line

Next Vial's intro price of $78 takes some of the cost out of the start, but plan around the $199/month standing price, since that is what you pay from then on. To see Next Vial against the wider field, use our ranked semaglutide providers; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.

The Bottom Line

Next Vial scores highest on state availability and ease of access.

Score: 7.1/10Best for: compounded GLP-1, LegitScript-certified, with a named pharmacy partnerFrom: $199/mo (after intro offer)

Ready to start with Next Vial?

From $199/mo (after intro offer). See current pricing and start your free consultation.

Next Vial might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If the lowest possible monthly price is your top priority, consider YourEra (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Head-to-head

Compare Next Vial vs…

Next Vial scores7.1/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Next Vial is an online telehealth marketplace that connects patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options. An independently licensed provider reviews your information and determines whether treatment is appropriate for you.
Next Vial offers compounded semaglutide and tirzepatide injections, including standard and microdose options, dispensed through Manifest Pharmacy in Greer, SC. Compounded medications are not FDA-approved brand-name products.
Compounded semaglutide is $199 month to month, or $169, $99 and $78 per month on 3-, 6- and 12-month prepaid plans; compounded tirzepatide is $249 month to month, or $229, $167 and $127 per month on the same plans. The price covers the online consultation, medication, and shipping, plus syringes and alcohol pads. Confirm current pricing on its site.
Next Vial lists availability in 49 states; Alaska is not included. Check its site to confirm your state is served.
Next Vial states there is no membership fee and one all-in price applies; it does not accept insurance, so plans are cash-pay. It notes that the same price applies across doses.
You start online by completing an intake so a board-certified provider can determine whether treatment is appropriate for you, with medication then dispensed by its named pharmacy partner. Review its terms for details on billing and cancellation.
Next Vial doesn't require a coupon code. New patients currently get an intro price of $78/mo (then $199/mo), applied automatically through the link on this page. Third-party "Next Vial promo code" sites are typically fake; the real offer is on Next Vial's checkout.
Next Vial is an operating telehealth provider, and we found no FDA warning letter on file for it. On its public pages, it shows LegitScript certification. We last checked its prices and policies on its own site in November 2026. We scored it 7.1/10 from published information, which is not a clinical endorsement. Talk to a licensed clinician before starting any medication.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Next Vial. The concerns our review flags: Lowest monthly rates require prepaying 6 or 12 months up front; Compounded medications are not FDA-approved; Labs and nutritional coaching not disclosed; Microdose pricing not published on product page. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Next Vial review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Next Vial's current pricing

Plans from $199/mo (after intro offer). Start your free consultation to check eligibility and today's price.